211 related articles for article (PubMed ID: 28439985)
21. Comparison of SPE, IFE, and FLC in Monitoring Patients with Multiple Myeloma After Autologous Stem Cell Transplantation.
Li W; Zhou JZ; Chang HR; Dai LJ; Zhu ZL; Feng YF; Gong FR; Wu DP
Cell Biochem Biophys; 2015 Dec; 73(3):643-7. PubMed ID: 27259306
[TBL] [Abstract][Full Text] [Related]
22. Serum free light chain measurement aids the diagnosis of myeloma in patients with severe renal failure.
Hutchison CA; Plant T; Drayson M; Cockwell P; Kountouri M; Basnayake K; Harding S; Bradwell AR; Mead G
BMC Nephrol; 2008 Sep; 9():11. PubMed ID: 18808676
[TBL] [Abstract][Full Text] [Related]
23. Screening Method for M-Proteins in Serum Using Nanobody Enrichment Coupled to MALDI-TOF Mass Spectrometry.
Kohlhagen MC; Barnidge DR; Mills JR; Stoner J; Gurtner KM; Liptac AM; Lofgren DI; Vanderboom PM; Dispenzieri A; Katzmann JA; Willrich MA; Snyder MR; Murray DL
Clin Chem; 2016 Oct; 62(10):1345-52. PubMed ID: 27515443
[TBL] [Abstract][Full Text] [Related]
24. Complementarily of urine analysis and serum free light chain assay for assessing response treatment response: illustrated by three case examples.
Levinson SS
Clin Chim Acta; 2011 Nov; 412(23-24):2206-10. PubMed ID: 21864518
[TBL] [Abstract][Full Text] [Related]
25. Screening panels for detection of monoclonal gammopathies.
Katzmann JA; Kyle RA; Benson J; Larson DR; Snyder MR; Lust JA; Rajkumar SV; Dispenzieri A
Clin Chem; 2009 Aug; 55(8):1517-22. PubMed ID: 19520758
[TBL] [Abstract][Full Text] [Related]
26. Detection of Plasma Cell Disorders by Mass Spectrometry: A Comprehensive Review of 19,523 Cases.
Dasari S; Kohlhagen MC; Dispenzieri A; Willrich MAV; Snyder MR; Kourelis TV; Lust JA; Mills JR; Kyle RA; Murray DL
Mayo Clin Proc; 2022 Feb; 97(2):294-307. PubMed ID: 34887112
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic performances of M-protein tests according to the clinical presentations of kidney disease.
Koo EH; Shin JH; Jang HR; Park HD; Kwon GY; Huh W; Kim DJ; Kim YG; Oh HY; Lee JE
Eur J Intern Med; 2016 Sep; 33():88-92. PubMed ID: 27421913
[TBL] [Abstract][Full Text] [Related]
28. Mass spectrometry for the evaluation of monoclonal proteins in multiple myeloma and related disorders: an International Myeloma Working Group Mass Spectrometry Committee Report.
Murray DL; Puig N; Kristinsson S; Usmani SZ; Dispenzieri A; Bianchi G; Kumar S; Chng WJ; Hajek R; Paiva B; Waage A; Rajkumar SV; Durie B
Blood Cancer J; 2021 Feb; 11(2):24. PubMed ID: 33563895
[TBL] [Abstract][Full Text] [Related]
29. Detection of kappa and lambda light chain monoclonal proteins in human serum: automated immunoassay versus immunofixation electrophoresis.
Jaskowski TD; Litwin CM; Hill HR
Clin Vaccine Immunol; 2006 Feb; 13(2):277-80. PubMed ID: 16467338
[TBL] [Abstract][Full Text] [Related]
30. Immunoglobulin-free light chain monomer-dimer patterns help to distinguish malignant from premalignant monoclonal gammopathies: a pilot study.
Kaplan B; Golderman S; Aizenbud B; Esev K; Kukuy O; Leiba M; Livneh A; Ben-Zvi I
Am J Hematol; 2014 Sep; 89(9):882-8. PubMed ID: 24866208
[TBL] [Abstract][Full Text] [Related]
31. Using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry to detect monoclonal immunoglobulin light chains in serum and urine.
Barnidge DR; Krick TP; Griffin TJ; Murray DL
Rapid Commun Mass Spectrom; 2015 Nov; 29(21):2057-60. PubMed ID: 26443406
[TBL] [Abstract][Full Text] [Related]
32. Relationship between monoclonal gammopathy and cardiac amyloid type.
Maleszewski JJ; Murray DL; Dispenzieri A; Grogan M; Pereira NL; Jenkins SM; Judge DP; Caturegli P; Vrana JA; Theis JD; Dogan A; Halushka MK
Cardiovasc Pathol; 2013; 22(3):189-94. PubMed ID: 23102805
[TBL] [Abstract][Full Text] [Related]
33. Detecting monoclonal immunoglobulins in human serum using mass spectrometry.
Mills JR; Barnidge DR; Murray DL
Methods; 2015 Jun; 81():56-65. PubMed ID: 25916620
[TBL] [Abstract][Full Text] [Related]
34. [Current status regarding detection of monoclonal component in Japan].
Yamada T
Rinsho Byori; 2010 Apr; 58(4):397-400. PubMed ID: 20496769
[TBL] [Abstract][Full Text] [Related]
35. Serum free light chains in clinical laboratory diagnostics.
Jenner E
Clin Chim Acta; 2014 Jan; 427():15-20. PubMed ID: 23999048
[TBL] [Abstract][Full Text] [Related]
36. Automation and validation of a MALDI-TOF MS (Mass-Fix) replacement of immunofixation electrophoresis in the clinical lab.
Kohlhagen M; Dasari S; Willrich M; Hetrick M; Netzel B; Dispenzieri A; Murray DL
Clin Chem Lab Med; 2020 Aug; 59(1):155-163. PubMed ID: 32745067
[TBL] [Abstract][Full Text] [Related]
37. Detection of serum M-protein in acetonitrile precipitates by MALDI-TOF mass spectrometry: A novel, low-cost methodology.
Mehra N; Gopisetty G; Subramani J; Dhanasekar S; Rajamanickam A; Perumal Kalaiyarasi J; Karunakaran P; Kannan K; Rajaraman S; Rajkumar T
Ann Clin Biochem; 2023 Sep; 60(5):339-348. PubMed ID: 37158306
[TBL] [Abstract][Full Text] [Related]
38. Serum monoclonal immunoglobulin light-chain detection differs between immunofixation electrophoresis methods in patients with AL amyloidosis.
Kawano Y; Nishimura N; Yasunaga JI
Int J Hematol; 2024 May; ():. PubMed ID: 38739302
[TBL] [Abstract][Full Text] [Related]
39. Interference of daratumumab in monitoring multiple myeloma patients using serum immunofixation electrophoresis can be abrogated using the daratumumab IFE reflex assay (DIRA).
van de Donk NW; Otten HG; El Haddad O; Axel A; Sasser AK; Croockewit S; Jacobs JF
Clin Chem Lab Med; 2016 Jun; 54(6):1105-9. PubMed ID: 26812873
[TBL] [Abstract][Full Text] [Related]
40. Serum free light chains for monitoring multiple myeloma.
Mead GP; Carr-Smith HD; Drayson MT; Morgan GJ; Child JA; Bradwell AR
Br J Haematol; 2004 Aug; 126(3):348-54. PubMed ID: 15257706
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
